Preclinical News and Research

RSS
HT, B.Braun partner to launch Adenocaine Hiberplegia syringe pump delivery system

HT, B.Braun partner to launch Adenocaine Hiberplegia syringe pump delivery system

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

EGT transfers clinical grade lentiviral vector to MSKCC

EGT transfers clinical grade lentiviral vector to MSKCC

UK MRC, Humabs discover first neutralizing antibody that targets all influenza A subtypes

UK MRC, Humabs discover first neutralizing antibody that targets all influenza A subtypes

'Systems biology' study of breast cancer

'Systems biology' study of breast cancer

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

Curis second quarter net loss increases to $4.9 million

Curis second quarter net loss increases to $4.9 million

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

MR-guided focused ultrasound prior to radiation therapy could treat cancer

MR-guided focused ultrasound prior to radiation therapy could treat cancer

New preclinical data from Baxter's BAX 499 hemophilia study presented at ISTH

New preclinical data from Baxter's BAX 499 hemophilia study presented at ISTH

New preclinical data suggests microRNA-15 inhibits cardiomyogenesis

New preclinical data suggests microRNA-15 inhibits cardiomyogenesis

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Selexis, CSL enter commercial license agreement for therapeutic antibody

Selexis, CSL enter commercial license agreement for therapeutic antibody

New hope for infants born with Spinal Muscular Atrophy

New hope for infants born with Spinal Muscular Atrophy

'Core-shell' nanoparticles for effective intracellular delivery of RNAi therapeutics

'Core-shell' nanoparticles for effective intracellular delivery of RNAi therapeutics

CNBG, Aeras sign MOU to develop TB vaccines in China and around the world

CNBG, Aeras sign MOU to develop TB vaccines in China and around the world

Adaptimmune announces opening of pilot clinical trial in synovial sarcoma

Adaptimmune announces opening of pilot clinical trial in synovial sarcoma

Promising drug for Duchenne muscular dystrophy

Promising drug for Duchenne muscular dystrophy

Nanoviricides lead anti-HIV candidate as good as HAART cocktail therapy

Nanoviricides lead anti-HIV candidate as good as HAART cocktail therapy

Researchers examine benefits of hyperbaric oxygen in treatment of aggressive brain cancer

Researchers examine benefits of hyperbaric oxygen in treatment of aggressive brain cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.